ORIC Pharmaceuticals, Inc. (ORIC) Misses Q2 EPS by 4c

ORIC Pharmaceuticals, Inc. (NASDAQ: ORIC) reported Q2 EPS of ($0.45), $0.04 worse than the analyst estimate of ($0.41).

For earnings history and earnings-related data on ORIC Pharmaceuticals, Inc. (ORIC) click here.

You May Also Be Interested In

• Klarna shares tumble on weak full-year revenue guidance
• Flash Sports posts $266M in assets after merger, net loss widens
• Goldman Sachs reviews US consumer staples sales data for August from NielsenIQ